AIP and metabolic syndrome: Firstly, the AIP serves as a reliable indicator of atherogenic dyslipidemia, a condition characterized by elevated TG, reduced HDL-C, and increased levels of small dense low-density lipoprotein (sdLDL)-an LDL subfraction with enhanced pro-inflammatory and pro-atherogenic properties (45).